Basics Arcutis Biotherapeutics, Inc. IPO Date: January 31, 2020 Sector: Healthcare Industry: Biotech Market Cap: $1.6B Activated in VL: True Average Daily Range Avg Daily Range: $0.58 | 3.45% Avg Daily Range (30 D): $0.33 | 2.38% Avg Daily Range (90 D): $0.46 | 3.33% Institutional Daily Volume Avg Daily Volume: 1.09M Avg Daily Volume (30 D): 1.66M Avg Daily Volume (90 D): 1.99M Trade Size Avg Trade Size (Sh.): 105 Avg Trade Size (Sh.) (30 D): 74 Avg Trade Size (Sh.) (90 D): 81 Institutional Trades Total Inst.Trades: 1,854 Avg Inst. Trade: $1.86M Avg Inst. Trade (30 D): $2.47M Avg Inst. Trade (90 D): $2.52M Avg Inst. Trade Volume: .16M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.35M Avg Closing Trade (30 D): $3.44M Avg Closing Trade (90 D): $3.63M Avg Closing Volume: 196.67K     News Jun 6, 2025 @ 8:00 PM Arcutis Biotherapeutics Reports Inducement Grants ... Source: N/A Jun 6, 2025 @ 12:00 PM Arcutis to Present New Long-Term Results of ZORYVE... Source: N/A May 6, 2025 @ 8:00 PM Arcutis Announces First Quarter 2025 Financial Res... Source: Arcutis Biotherapeutics, Inc. Apr 18, 2025 @ 8:26 AM Atopic Dermatitis Drugs Market Forecast 2025-2034 ... Source: Researchandmarkets.Com Mar 7, 2025 @ 1:00 PM Arcutis to Highlight Data from Phase 3 Trials for ... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $-1.03 $-.2 $-.08 Diluted EPS $-1.03 $-.2 $-.08 Revenue $ 212.82M $ 65.85M $ 71.36M Gross Profit $ 188.12M $ 57.02M $ 64.46M Net Income / Loss $ -129.72M $ -25.06M $ -10.79M Operating Income / Loss $ -121.3M $ -24.53M $ -7.63M Cost of Revenue $ 24.7M $ 8.83M $ 6.91M Net Cash Flow $ -136.84M $ -18.24M $ -63.28M PE Ratio